Giredestrant plus everolimus reduced the risk of progression or death by 44% in the ITT population and 62% in ESR1-mutated disease in phase 3 evERA data published in NEJM.
Feature|Articles|March 3, 2026
Medicaid Expansion Leads to Long-Term Survival Trends in Breast Cancer
Author(s)Sabrina Serani, Oluwasegun Akinyemi, MD, PhD
Fact checked by: Paige Britt
New study links Medicaid expansion to sustained breast cancer survival gains, revealing uneven benefits by race and urging policy action.
Advertisement
Advertisement
For Oluwasegun Akinyemi, MD, PhD, the journey toward researching US health policy began thousands of miles away. As an obstetrician and gynecologist in Nigeria, Akinyemi witnessed a recurring, heartbreaking pattern: women presenting with advanced-stage diseases when clinical intervention could offer little hope. This experience fueled a career transition from the bedside to the legislative data sheet.
Related to this article
Benjamin Herzberg, MD, discusses KRAS-mutant non–small cell lung cancer, upfront biomarker testing, and the emerging RAS inhibitor toolkit on Targeted Talks.
Broad oncology bundles falter; experts push smaller surgery/radiation episodes, better navigation, and AI analytics to improve value-based care.
Elinzanetant, already approved for menopause-related VMS, is being considered to address hot flashes associated with adjuvant breast cancer endocrine therapy.
In an interview, Peter Voorhees, MD, discusses his presentation of the CERVINO trial data from the International Myeloma Society meeting.
New analysis tracks life-years gained from blood cancer therapies, revealing breakthrough inflection points, stubborn AML gaps, and inequities in access.
For Prostate Cancer Awareness Month, Herbert Lepor, MD, discusses the leading concerns in managing early prostate cancer and tailoring strategies to the patient based on their risk and goals.
The oral azacitidine/cedazuridine combination was compared with subcutaneous azacitidine in the phase 3 portion of the AZTOUND trial.
Advertisement
Advertisement